United States securities and exchange commission logo





                          February 28, 2024

       Jerel Banks, M.D., Ph.D.
       Chief Executive Officer
       Benitec Biopharma Inc.
       3940 Trust Way
       Hayward, CA 94545

                                                        Re: Benitec Biopharma
Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed February 23,
2024
                                                            File No. 333-277310

       Dear Jerel Banks:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Doris
Stacey Gama at 202-551-3188 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Louis Rambo, Esq.